MELIGAMET 50/850 MG TABLET: Advanced Management for Type 2 Diabetes

MELIGAMET 50/850 MG Tablet is a specialized prescription medication engineered to provide comprehensive glycemic control for individuals living with Type 2 Diabetes. This oral tablet combines the synergistic actions of Vildagliptin and Metformin Hydrochloride, targeting multiple pathways to effectively lower blood sugar levels.

By improving the body's sensitivity to insulin and reducing the liver's glucose production, Meligamet aids in achieving optimal blood glucose management. It is designed to help control both fasting and post-meal glucose spikes, contributing to overall well-being as part of a tailored treatment plan including diet and exercise.

Key Benefits:

• Effectively lowers and stabilizes blood glucose levels.
• Improves insulin sensitivity and reduces hepatic glucose production.
• Manages both fasting plasma glucose and post-prandial glucose.
• Contributes to comprehensive glycemic control for Type 2 Diabetes.
• Supports long-term diabetes management when combined with lifestyle interventions.

How to Use:

1. Take MELIGAMET 50/850 MG Tablet exactly as prescribed by your healthcare professional.
2. It is typically taken orally, usually once or twice daily.
3. Administer the tablet with meals to help minimize gastrointestinal side effects.
4. Swallow the tablet whole with water; do not crush, chew, or break it.
5. Adhere strictly to your physician's recommended dosage and regimen for optimal results.
6. Combine with a balanced diet and regular exercise, as advised by your doctor, for best glycemic control.

Caution & Warnings:

• Hypoglycemia Risk: May cause low blood sugar, especially when used with other antidiabetic medications or without adequate food intake. Be aware of symptoms and carry a source of glucose.
• Lactic Acidosis: Metformin carries a rare but serious risk of lactic acidosis. Seek immediate medical attention if you experience symptoms like unusual muscle pain, trouble breathing, stomach pain, or dizziness.
• Renal Impairment: Not recommended for patients with severe kidney problems. Regular monitoring of kidney function is crucial.
• Hepatic Impairment: Use with caution in patients with liver conditions.
• Heart Failure: Inform your doctor if you have a history of heart failure.
• Not for Type 1 Diabetes: This medication is specifically for Type 2 Diabetes and not indicated for Type 1 Diabetes or diabetic ketoacidosis.
• Pregnancy and Breastfeeding: Consult your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
• Medical Procedures: Inform your doctor you are taking Meligamet before any surgical procedures or radiological studies involving iodinated contrast agents.
• Do not exceed the prescribed dosage. Always keep out of reach of children.

Ingredients:

• Each tablet contains:
• Vildagliptin: 50 mg
• Metformin Hydrochloride: 850 mg

Product Details:

• Brand: Meligamet
• Manufacturer: EGYPHAR
• Drug Type: Prescription Medication
• Form: Oral Tablet
• Strength: 50 mg Vildagliptin / 850 mg Metformin HCl
• Administration Route: Oral